v3.25.0.1
Basis of Presentation (Tables)
9 Months Ended 12 Months Ended
Sep. 30, 2024
Dec. 31, 2023
Basis of Presentation    
Reconciliation of cash, cash equivalents and restricted cash  

The following table provides a reconciliation of cash, cash equivalents and restricted cash reported in the consolidated balance sheets to the same total reported in the consolidated statements of cash flows (in thousands):

December 31, 

December 31, 

2023

    

2022

Cash and cash equivalents

$

4,459

$

3,855

Restricted cash

100

100

Total cash, cash equivalents, and restricted cash in the consolidated statement of cash flows

$

4,559

$

3,955

Schedule of anti-dilutive securities

The following table sets forth the potential shares of common stock that are not included in the calculation of diluted net loss per share because to do so would be anti-dilutive as of the end of each period presented:

September 30, 

    

2024

    

2023

Stock options

 

144

 

305

Unvested restricted stock units

8

45

Convertible preferred stock

10

10

Warrants

 

81,432

 

28,147

December 31, 

    

2023

    

2022

Stock options

 

216

 

370

Unvested restricted stock units

25

79

Convertible preferred stock

10

10

Warrants

 

268,937

 

3,336